Works matching IS 01615505 AND DT 2025 AND VI 66 AND IP 6

Results: 33

Funding Reductions Threaten the Future of Medical Innovation.

Published in:

2025

By:

Czernin, Johannes;
Anderson, Carolyn J.;
Badawi, Ramsey Derek;
Barthel, Henryk;
Bengel, Frank M.;
Beyer, Thomas;
Buvat, Irene;
Calais, Jérémie;
Dorbala, Sharmila;
Drzezga, Alexander E.;
Herrmann, Ken;
Hope, Thomas A.;
Jadvar, Hossein;
Mankoff, David A.;
Schelbert, Heinrich R.;
Weber, Wolfgang A.

Publication type:

Editorial

Stakeholders of Theranostics: Thomas Beyer Talks with Richard Zimmermann About the Golden Age of Nuclear Medicine.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 6, p. 830, doi. 10.2967/jnumed.125.270085

By:

Zimmermann, Richard;
Beyer, Thomas

Publication type:

Article

Reply to "The Randomized, Phase 2 LuCAP Study".

Published in:

2025

By:

Satapathy, Swayamjeet;
Sood, Ashwani

Publication type:

Letter

2024 SNMMI Highlights Lecture: Cardiovascular Sciences.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 6, p. 856, doi. 10.2967/jnumed.125.269988

By:

Thackeray, James T.

Publication type:

Article

FDA Reconsiders Rules Around Radiation Dosimetry for First-in-Human Studies of Investigational PET Radiopharmaceuticals.

Published in:

2025

By:

Dakanali, Marianna;
Zigler, Steven S.;
Schwarz, Sally W.;
Nickels, Michael L.;
Oyama, Reiko;
VanBrocklin, Henry F.;
Scott, Peter J. H.

Publication type:

Letter

Business Model Beats Science and Logic: Dosimetry and Paucity of Its Use.

Published in:

2025

By:

Goldenberg, Michael D.F.;
Gill, Taranjit S.;
Dhingra, Jitesh

Publication type:

Letter

CD70-Targeted [18F]RCCB6 Immuno-PET/CT Imaging in Patients with Nasopharyngeal Carcinoma: A Proof-of-Concept Study.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 6, p. 865, doi. 10.2967/jnumed.125.269585

By:

Shi, Binyu;
Zhang, You;
Wu, Shuo;
Xu, Dongsheng;
Wu, Qianyun;
Jia, Wenzhi;
An, Shuxian;
Wang, Cheng;
Bai, Yongrui;
Liu, Jianjun;
Zhou, Junjun;
Wei, Weijun

Publication type:

Article

The Randomized, Phase 2 Trial LuCAP Study.

Published in:

2025

By:

Tuncel, Murat;
Kaya, Gürsan;
Kodaz, Oğuz;
Türkan, Cem;
Tuncalı, Meltem Çağlar

Publication type:

Letter

Diagnostic Radiopharmaceutical Trial Design: Is It Time to Change Nomenclature?

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 6, p. 848, doi. 10.2967/jnumed.125.269496

By:

Hicks, Rodney J.

Publication type:

Article

The Role of PSMA PET Parameters as Biomarkers for Response to PSMA-Targeted Radiopharmaceutical Therapy.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 6, p. 833, doi. 10.2967/jnumed.124.268818

By:

Murthy, Vishnu;
Ludwig, Vinicius;
Gafita, Andrei;
Hope, Thomas A.;
Calais, Jeremie

Publication type:

Article

Safety and Efficacy of 20 Cycles of [177Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 6, p. 981, doi. 10.2967/jnumed.124.269447

By:

Jewell, Kerry E.;
Buteau, James P.;
Medhurst, Elizabeth;
Kwan, Edmond M.;
Sandhu, Shahneen;
Azad, Arun A.;
Hofman, Michael S.

Publication type:

Article

Multicycle Dosimetric Behavior and Dose–Effect Relationships in [177Lu]Lu-DOTATATE Peptide Receptor Radionuclide Therapy.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 6, p. 900, doi. 10.2967/jnumed.124.269389

By:

Kayal, Gunjan;
Roseland, Molly E.;
Wang, Chang;
Fitzpatrick, Kellen;
Mirando, David;
Suresh, Krithika;
Wong, Ka Kit;
Dewaraja, Yuni K.

Publication type:

Article

Initial Experience with Dual-Time-Point [18F]Flurpiridaz PET/CT for Localization of Parathyroid Adenomas in Primary Hyperparathyroidism.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 6, p. 922, doi. 10.2967/jnumed.124.269387

By:

Derlin, Thorsten;
Kleine-Döpke, Dennis;
Neubert, Lavinia;
Ross, Tobias L.;
Ringe, Bastian P.;
Schmelzle, Moritz;
Bengel, Frank M.

Publication type:

Article

Prostate Cancer Recurrence Due to Isolated Testicular Metastases Detected by PSMA PET/CT.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 6, p. 892, doi. 10.2967/jnumed.124.269361

By:

de Oliveira Taveira, Mateus;
Razmaria, Ali Aria;
Schoder, Heiko;
Yeh, Randy

Publication type:

Article

First-in-Human Serum Stability Studies of [177Lu]Lu-AMTG: A Step Toward Improved GRPR-Targeted Radiopharmaceutical Therapy.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 6, p. 896, doi. 10.2967/jnumed.124.269132

By:

Felber, Veronika;
Holzleitner, Nadine;
Joksch, Markus;
Suhrbier, Tim;
von Amsberg, Gunhild;
Schwarzenböck, Sarah;
Kurth, Jens;
Heuschkel, Martin;
Günther, Thomas;
Krause, Bernd J.

Publication type:

Article

First-in-Human Study of 18F-Labeled PET Tracer for Glutamate AMPA Receptor [18F]K-40: A Derivative of [11C]K-2.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 6, p. 932, doi. 10.2967/jnumed.124.269405

By:

Ichijo, Sadamitsu;
Arisawa, Tetsu;
Hatano, Mai;
Nakajima, Waki;
Miyazaki, Tomoyuki;
Eiro, Tsuyoshi;
Takada, Yuuki;
Iai, Ryunosuke;
Sano, Akane;
Sonoda, Masaki;
Takayama, Yutaro;
Kimura, Yuichi;
Takahashi, Takuya

Publication type:

Article

[68Ga]Ga-RAYZ-8009: A Peptide PET Tracer for Targeting HCC in Humans.

Published in:

2025

By:

Zhang, Yue;
Yue, Jiangtao;
Yang, Xuhong;
Fei, Guanghai;
Ni, Yicheng;
Li, Yue

Publication type:

Letter

Feasibility of Ultra-Low-Activity 18F-FDG PET/CT Imaging Using a Long–Axial-Field-of-View PET/CT System.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 6, p. 961, doi. 10.2967/jnumed.124.269272

By:

Smith, Charlotte L.C.;
Zwezerijnen, Gerben J. C.;
den Hollander, Marijke E.;
Zijlstra, Josée M.;
Menke-van der Houven van Oordt, C. Willemien;
Bahce, Idris;
Yaqub, Maqsood;
Boellaard, Ronald

Publication type:

Article

212Bi-Macroaggregated Albumin Inhibited Mouse Melanoma Growth by Regulating Cell Cycle Checkpoint Markers Without Promoting Living Cell Repopulation.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 6, p. 916, doi. 10.2967/jnumed.124.269190

By:

Singh, Satyendra Kumar;
Kauffman, Nathan;
Lynch, Isabelle Maria;
Kunt, Zeynep Meral;
Zinn, Kurt R.;
Agnew, Dalen;
Fan, Jinda

Publication type:

Article

FDA Approval of 18F-Flurpiridaz for PET: Stepping into a New Era of Myocardial Perfusion Imaging?

Published in:

2025

By:

Schindler, Thomas H.;
Bateman, Timothy M.;
Berman, Daniel S.;
Chareonthaitawee, Panithaya;
De Blanche, Lorraine E.;
Dilsizian, Vasken;
Dorbala, Sharmila;
Gropler, Robert J.;
Shaw, Leslee L.;
Soman, Prem;
Winchester, David E.;
Verberne, Hein J.;
Ahuja, Sukhjeet;
Beanlands, Rob;
Di Carli, Marcelo;
Murthy, Venkatesh L.;
Ruddy, Terrence D.;
Schwartz, Ronald G.

Publication type:

Editorial

161Tb Radioimmunotherapy as a Treatment for CD30-Positive Lymphomas.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 6, p. 909, doi. 10.2967/jnumed.124.268805

By:

Rioja-Blanco, Elisa;
Banz, Yara;
Schlapbach, Christoph;
Novak, Urban;
Chiorazzo, Tanja;
Bertschi, Nicole L.;
Bernhardt, Peter;
Grundler, Pascal V.;
van der Meulen, Nicholas P.;
Grzmil, Michal;
Schibli, Roger;
Behe, Martin

Publication type:

Article

Detection of HER2-Low Lesions Using HER2-Targeted PET Imaging in Patients with Metastatic Breast Cancer: A Paired HER2 PET and Tumor Biopsy Analysis.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 6, p. 873, doi. 10.2967/jnumed.124.269227

By:

Yeh, Randy;
Pareja, Fresia;
Shobeiri, Parnian;
Ross, Dara;
Jayaprakasam, Vetri S.;
Razmaria, Ali Aria;
Drago, Joshua Z.;
Mauguen, Audrey;
Lyashchenko, Serge K.;
Zeglis, Brian M.;
Lewis, Jason S.;
Ulaner, Gary A.

Publication type:

Article

Is Long–Axial-Field-of-View PET/CT Cost-Effective? An International Health–Economic Analysis.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 6, p. 954, doi. 10.2967/jnumed.124.269203

By:

Alberts, Ian;
More, Stuart;
Knapp, Karen;
Mei, Riccardo;
Fanti, Stefano;
Mingels, Clemens;
Nardo, Lorenzo;
Hammond, Nii Boye;
Nagaraj, Harish;
Rominger, Axel;
Cook, Gary J.R.;
Wilson, Don

Publication type:

Article

Quantitative Total-Body Imaging of Blood Flow with High-Temporal-Resolution Early Dynamic 18F-FDG PET Kinetic Modeling.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 6, p. 973, doi. 10.2967/jnumed.124.268706

By:

Chung, Kevin J.;
Chaudhari, Abhijit J.;
Nardo, Lorenzo;
Jones, Terry;
Chen Jr., Moon S.;
Badawi, Ramsey D.;
Cherry, Simon R.;
Wang, Guobao

Publication type:

Article

In Vivo Visualization and Quantification of Brain Heat Shock Protein 90 with [11C]HSP990 in Healthy Aging and Neurodegeneration.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 6, p. 940, doi. 10.2967/jnumed.124.268961

By:

Cools, Romy;
Vermeulen, Koen;
Vonck, Eline;
Baekelandt, Veerle;
Varlow, Cassis;
Narykina, Valeria;
Cawthorne, Christopher;
Van Laere, Koen;
Vanduffel, Wim;
Vasdev, Neil;
Bormans, Guy

Publication type:

Article

Targeting Extra Domain A of Fibronectin to Improve Noninvasive Detection of Triple-Negative Breast Cancer.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 6, p. 880, doi. 10.2967/jnumed.124.268859

By:

Hachey, Justin S.;
Viray, Tara D.;
Matasci, Mattia;
Ravazza, Domenico;
Neri, Dario;
Lewis, Jason S.

Publication type:

Article

Feasibility of an Ultra-Low-Dose PET Scan Protocol with CT-Based and LSO-TX–Based Attenuation Correction Using a Long–Axial-Field-of-View PET/CT Scanner.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 6, p. 967, doi. 10.2967/jnumed.124.268380

By:

Sari, Hasan;
Teimoorisichani, Mohammadreza;
Viscione, Marco;
Mingels, Clemens;
Seifert, Robert;
Shi, Kuangyu;
Morris, Michael;
Siegel, Eliot;
Saboury, Babak;
Pyka, Thomas;
Rominger, Axel

Publication type:

Article

[18F]Florzolotau PET for the Differential Diagnosis of Parkinsonism in Patients with Suspected 4-Repeat Tauopathies.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 6, p. 926, doi. 10.2967/jnumed.124.268956

By:

Brumberg, Joachim;
Schröter, Nils;
Blazhenets, Ganna;
Omrane, M. Aymen;
Volz, Christian;
Weiller, Cornelius;
Rijntjes, Michel;
Frings, Lars;
Hellwig, Sabine;
Jost, Wolfgang H.;
Meyer, Philipp T.

Publication type:

Article

An External, Independent Validation of an O -(2-[18F]Fluoroethyl)-l-Tyrosine PET Automatic Segmentation Network on a Single-Center, Prospective Dataset of Patients with Glioblastoma.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 6, p. 948, doi. 10.2967/jnumed.124.268925

By:

Barry, Nathaniel;
Kendrick, Jake;
Rowshanfarzad, Pejman;
Hassan, Ghulam Mubashar;
Francis, Roslyn J.;
Bucknell, Nicholas;
Koh, Eng-Siew;
Scott, Andrew M.;
Ebert, Martin A.;
Gutsche, Robin;
Ciantar, Keith George;
Galldiks, Norbert;
Langen, Karl-Josef;
Lohmann, Philipp

Publication type:

Article

Patient-Specific Dosimetry-Driven PRRT: Time to Move Forward!

Published in:

2025

By:

Deshayes, Emmanuel;
Karfis, Ioannis;
Santoro, Lore;
Mileva, Magdalena;
Danieli, Rachele;
Hebert, Kévin;
Maccauro, Marco;
Chiesa, Carlo;
Bardiès, Manuel

Publication type:

Letter

Approaches to Imaging Immune Activation Using PET.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 6, p. 839, doi. 10.2967/jnumed.124.268289

By:

Parihar, Ashwin Singh;
Pant, Niharika;
Heidari, Pedram;
Fong, Lawrence;
Iravani, Amir

Publication type:

Article

Determination of the Intralesional Distribution of Theranostic 124I-Omburtamab Convection-Enhanced Delivery in Treatment of Diffuse Intrinsic Pontine Glioma.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 6, p. 886, doi. 10.2967/jnumed.124.267995

By:

França Velo, Alexandre;
Giantini Larsen, Alexandra;
Humm, John L.;
Zanzonico, Pat;
Haque, Sofia;
Souweidane, Mark;
Pandit-Taskar, Neeta

Publication type:

Article

From Genome to Phenome: Opportunities and Challenges of Molecular Imaging.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 6, p. 851, doi. 10.2967/jnumed.124.267660

By:

Tian, Mei;
Hood, Leroy;
Chiti, Arturo;
Schwaiger, Markus;
Minoshima, Satoshi;
Watanabe, Yasuyoshi;
Kang, Keon Wook;
Zhang, Hong

Publication type:

Article

Works matching IS 01615505 AND DT 2025 AND VI 66 AND IP 6

Funding Reductions Threaten the Future of Medical Innovation.

Stakeholders of Theranostics: Thomas Beyer Talks with Richard Zimmermann About the Golden Age of Nuclear Medicine.

Reply to "The Randomized, Phase 2 LuCAP Study".

2024 SNMMI Highlights Lecture: Cardiovascular Sciences.

FDA Reconsiders Rules Around Radiation Dosimetry for First-in-Human Studies of Investigational PET Radiopharmaceuticals.

Business Model Beats Science and Logic: Dosimetry and Paucity of Its Use.

CD70-Targeted [<sup>18</sup>F]RCCB6 Immuno-PET/CT Imaging in Patients with Nasopharyngeal Carcinoma: A Proof-of-Concept Study.

The Randomized, Phase 2 Trial LuCAP Study.

Diagnostic Radiopharmaceutical Trial Design: Is It Time to Change Nomenclature?

The Role of PSMA PET Parameters as Biomarkers for Response to PSMA-Targeted Radiopharmaceutical Therapy.

Safety and Efficacy of 20 Cycles of [<sup>177</sup>Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.

Multicycle Dosimetric Behavior and Dose–Effect Relationships in [<sup>177</sup>Lu]Lu-DOTATATE Peptide Receptor Radionuclide Therapy.

Initial Experience with Dual-Time-Point [<sup>18</sup>F]Flurpiridaz PET/CT for Localization of Parathyroid Adenomas in Primary Hyperparathyroidism.

Prostate Cancer Recurrence Due to Isolated Testicular Metastases Detected by PSMA PET/CT.

First-in-Human Serum Stability Studies of [<sup>177</sup>Lu]Lu-AMTG: A Step Toward Improved GRPR-Targeted Radiopharmaceutical Therapy.

First-in-Human Study of <sup>18</sup>F-Labeled PET Tracer for Glutamate AMPA Receptor [<sup>18</sup>F]K-40: A Derivative of [<sup>11</sup>C]K-2.

[<sup>68</sup>Ga]Ga-RAYZ-8009: A Peptide PET Tracer for Targeting HCC in Humans.

Feasibility of Ultra-Low-Activity <sup>18</sup>F-FDG PET/CT Imaging Using a Long–Axial-Field-of-View PET/CT System.

<sup>212</sup>Bi-Macroaggregated Albumin Inhibited Mouse Melanoma Growth by Regulating Cell Cycle Checkpoint Markers Without Promoting Living Cell Repopulation.

FDA Approval of <sup>18</sup>F-Flurpiridaz for PET: Stepping into a New Era of Myocardial Perfusion Imaging?

<sup>161</sup>Tb Radioimmunotherapy as a Treatment for CD30-Positive Lymphomas.

Detection of HER2-Low Lesions Using HER2-Targeted PET Imaging in Patients with Metastatic Breast Cancer: A Paired HER2 PET and Tumor Biopsy Analysis.

Is Long–Axial-Field-of-View PET/CT Cost-Effective? An International Health–Economic Analysis.

Quantitative Total-Body Imaging of Blood Flow with High-Temporal-Resolution Early Dynamic <sup>18</sup>F-FDG PET Kinetic Modeling.

In Vivo Visualization and Quantification of Brain Heat Shock Protein 90 with [<sup>11</sup>C]HSP990 in Healthy Aging and Neurodegeneration.

Targeting Extra Domain A of Fibronectin to Improve Noninvasive Detection of Triple-Negative Breast Cancer.

Feasibility of an Ultra-Low-Dose PET Scan Protocol with CT-Based and LSO-TX–Based Attenuation Correction Using a Long–Axial-Field-of-View PET/CT Scanner.

[<sup>18</sup>F]Florzolotau PET for the Differential Diagnosis of Parkinsonism in Patients with Suspected 4-Repeat Tauopathies.

An External, Independent Validation of an O -(2-[<sup>18</sup>F]Fluoroethyl)-l-Tyrosine PET Automatic Segmentation Network on a Single-Center, Prospective Dataset of Patients with Glioblastoma.

Patient-Specific Dosimetry-Driven PRRT: Time to Move Forward!

Approaches to Imaging Immune Activation Using PET.

Determination of the Intralesional Distribution of Theranostic <sup>124</sup>I-Omburtamab Convection-Enhanced Delivery in Treatment of Diffuse Intrinsic Pontine Glioma.

From Genome to Phenome: Opportunities and Challenges of Molecular Imaging.